| Literature DB >> 30597877 |
Carolyn E Horne1, Tamara S Goda2, L Wiley Nifong3, Alan P Kypson4, Wesley T O'Neal5, Linda C Kindell6, Charulata Jindal7,8, Jimmy T Efird9,10.
Abstract
An assumption regarding transcatheter aortic valve replacement (TAVR), a minimally invasive procedure for treating aortic stenosis, is that patients remain at, or near baseline and soon return to their presurgical home to resume activities of daily living. However, this does not consistently occur. The purpose of this study was to identify preoperative factors that optimally predict discharge to a skilled nursing facility (SNF) after TAVR. Delineation of these conditions is an important step in developing a risk stratification model to assist in making informed decisions. Data was extracted from the American College of Cardiology (ACC) transcatheter valve therapy (TVT) registry and the Society of Thoracic Surgeons (STS) database on 285 patients discharged from 2012⁻2017 at a tertiary referral heart institute located in the southeastern region of the United States. An analysis of assessment, clinical and demographic variables was used to estimate relative risk (RR) of discharge to a SNF. The majority of participants were female (55%) and white (84%), with a median age of 82 years (interquartile range = 9). Approximately 27% (n = 77) were discharged to a SNF. Age > 75 years (RR = 2.3, p = 0.0026), female (RR = 1.6, p = 0.019), 5-meter walk test (5MWT) >7 s (RR = 2.0, p = 0.0002) and not using home oxygen (RR = 2.9, p = 0.0084) were identified as independent predictive factors for discharge to a SNF. We report a parsimonious risk-stratification model that estimates the probability of being discharged to a SNF following TAVR. Our findings will facilitate making informed treatment decisions regarding this older patient population.Entities:
Keywords: aortic stenosis; risk stratification; skilled nursing facility; transcatheter aortic valve replacement
Mesh:
Year: 2018 PMID: 30597877 PMCID: PMC6339195 DOI: 10.3390/ijerph16010073
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Patient characteristics by discharge location, following TAVR (N = 285).
| Characteristic | Discharge Location | ||
|---|---|---|---|
|
|
| ||
| Overall (n) | 77 | 208 | |
| Demographics | |||
| Age (y) | 83 {7} | 81 {10} | 0.0026 |
| Female | 48 (62) | 80 (36) | 0.0005 |
| White | 62 (81) | 177 (85) | 0.38 |
| Assessment | |||
| AF/Flutter | 33 (43) | 70 (34) | 0.17 |
| Cardiogenic shock (w/in 24 h) | 3 (4) | 2 (1) | 0.12 |
| Carotid stenosis | 29 (38) | 51 (25) | 0.037 |
| CLD (-) | 46 (60) | 82 (39) | 0.0030 |
| Current dialysis | 5 (6) | 11 (5) | 0.77 |
| Current/Recent smoker | 73 (95) | 184 (88) | 0.12 |
| Diabetes | 41 (53) | 90 (43) | 0.14 |
| 5MWT (s) (pre-TAVR) | 8 {6} | 6 {3} | <0.0001 |
| HF (w/in 2 w) | 1 (1) | 1 (<1) | 0.47 |
| Home O2 (-) | 74 (96) | 180 (87) | 0.019 |
| HTN | 73 (95) | 187 (90) | 0.24 |
| KCCQ-12 (pre-TAVR summary score) | 37 {26} | 36 {26} | 0.81 |
| NYHA (class 3–4) | 66 (86) | 173 (83) | 0.72 |
| Permanent pacemaker | 11 (14) | 20 (10) | 0.29 |
| Porcelain aorta | 75 (97) | 200 (96) | 1.0 |
| Prior AV procedure | 11 (14) | 27 (13) | 0.84 |
| Prior CABG | 61 (79) | 143 (69) | 0.10 |
| Prior CVA | 18 (23) | 33 (16) | 0.16 |
| Prior MI | 33 (43) | 83 (40) | 0.68 |
| Prior PCI | 30 (39) | 79 (38) | 0.89 |
| Clinical | |||
| Aortic insufficiency | 59 (77) | 161 (77) | 0.88 |
| AV peak velocity (m/s) | 4 {1} | 4 {1} | 0.53 |
| CPB | 11 (14) | 11 (5) | 0.023 |
| Diseased vessels (-) | 28 (36) | 61 (29) | 0.25 |
| Non-elective procedure | 21 (27) | 35 (17) | 0.064 |
| MV disease | 72 (94) | 184 (88) | 0.27 |
| Tricuspid insufficiency | 57 (74) | 139 (67) | 0.31 |
† Presurgical. * Fisher’s exact test (categorical variables) or Deuchler-Wilcoxon test (continuous variables). AF = Atrial fibrillation. AV = Aortic valve. CLD = Chronic lung disease. CPB = Cardiopulmonary bypass. CVA = Cerebrovascular accident. CABG = Coronary artery bypass. 5MWT = 5-meter walk test (preoperative gait speed over 5 m). h = Hours. HF = Heart failure HTN = Hypertension. IQR = Interquartile range. KCCQ-12 = Kansas City cardiomyopathy questionnaire (12 items). m = Meters. (-) = Negative (Not present/Not receiving). MI = Myocardial infarction. MV = Mitral valve. NYHA = New York Heart Association. O2 = Oxygen. PCI = Percutaneous coronary intervention. s = Seconds. SNF = Skilled nursing facility. TAVR = Transcatheter aortic valve replacement. w = Weeks. y = Years.
Multivariable risk model for discharge to a skilled nursing facility following TAVR (N = 285).
| Characteristic * | RR (95% CI) | |
|---|---|---|
| Age > 75 years | 2.3 (1.2–4.5) | 0.0026 |
| Female | 1.6 (1.1–2.3) | 0.019 |
| 5MWT > 7 s ‡ | 2.0 (1.4–3.0) | 0.0002 |
| Home oxygen (-) | 2.9 (1.01–8.5) | 0.0084 |
* Variable included in model if p < 0.025 and RR > 1.5 (or <0.67) in univariable analysis. Likelihood ratio test (log-binomial regression model). ‡ Cutoff point based on median value. 5MWT = 5-meter walk test (preoperative gait speed over 5 m). CI = Confidence interval (Wald method). (-) = Negative (Not receiving). RR = Relative risk. s = Seconds. TAVR = Transcatheter aortic valve replacement.
Risk stratification matrix for TAVR procedure (N = 285).
| Characteristic | Probability of Discharge to SNF * | 95% Confidence Interval † | |||
|---|---|---|---|---|---|
| Age | Sex | 5MWT | Home Oxygen | ||
| >75 years | Female | >7 s | Negative (-) | 0.59 | 0.54–0.65 |
| Positive (+) | 0.20 | 0.16–0.25 | |||
| ≤7 s | Negative (-) | 0.29 | 0.24–0.35 | ||
| Positive (+) | 0.10 | 0.07–0.14 | |||
| >75 years | Male | >7 s | Negative (-) | 0.39 | 0.32–0.44 |
| Positive (+) | 0.13 | 0.09–0.17 | |||
| ≤7 s | Negative (-) | 0.19 | 0.14–0.23 | ||
| Positive (+) | 0.06 | 0.04–0.10 | |||
| ≤75 years | Female | >7 s | Negative (-) | 0.26 | 0.21–0.31 |
| Positive (+) | 0.09 | 0.06–0.12 | |||
| ≤7 s | Negative (-) | 0.13 | 0.09–0.17 | ||
| Positive (+) | 0.04 | 0.02–0.07 | |||
| ≤75 years | Male | >7 s | Negative (-) | 0.16 | 0.12–0.21 |
| Positive (+) | 0.06 | 0.03–0.09 | |||
| ≤7 s | Negative (-) | 0.08 | 0.05–0.11 | ||
| Positive (+) | 0.03 | 0.01–0.05 | |||
* Log-binomial regression model. † Arcsine method. 5MWT = 5-m walk test (preoperative gait speed over 5 m). s = Seconds. TAVR = Transcatheter aortic valve replacement.